Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
- 28 September 2016
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 35 (1) , 35.e15-35.e19
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a–T1b Renal Mass and Normal Preoperative Renal FunctionEuropean Urology, 2015
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic ParametersAmerican Journal of Surgical Pathology, 2013
- Chromophobe Renal Cell CarcinomaAmerican Journal of Surgical Pathology, 2012
- A Non–Cancer-Related Survival Benefit Is Associated With Partial NephrectomyEuropean Urology, 2012
- Partial Nephrectomy Versus Radical Nephrectomy in Patients With Small Renal Tumors—Is There a Difference in Mortality and Cardiovascular Outcomes?Journal of Urology, 2009
- 2004 WHO Classification of the Renal Tumors of the AdultsEuropean Urology, 2006
- SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCEJournal of Urology, 2004
- Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinomaAnnals of Surgical Oncology, 2004
- Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial NeoplasmsAmerican Journal of Surgical Pathology, 2002